Sequential changes of serum aminotransferase levels in severely obese patients after losing weight through enrollment in a behavioral weight loss program

Postgraduate Medicine

Volumn 122, Issue 4, 2010, Pages 206-212

  Jhaveri, Manan A ^a   Anderson, James W ^b  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Nonalcoholic fatty liver disease; Obesity; Serum aminotransferase levels; Therapeutic lifestyle changes; Weight loss

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; AMINOTRANSFERASE; BIOLOGICAL MARKER;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; TREATMENT DURATION; WEIGHT REDUCTION; BEHAVIOR THERAPY; BLOOD; BODY MASS; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; REGRESSION ANALYSIS; TREATMENT OUTCOME;

ADULT; ALANINE TRANSAMINASE; BEHAVIOR THERAPY; BIOLOGICAL MARKERS; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; OBESITY; REGRESSION ANALYSIS; RISK FACTORS; TRANSAMINASES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 77956634663     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.07.2188     Document Type: Article

References (18)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16):1221-1231.
2. Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396-1402.
3. Hsiao PJ, Kuo KK, Shin SJ, et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gastroenterol Hepatol. 2007;22(12):2118-2123.
4. Suzuki A, Angulo P, Lymp J, et al. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology. 2005;41(1):64-71.
5. Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997;27(1):103-107.
6. Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol. 1991;12(2):224-229.
7. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990;99(5): 1408-1413.
8. Csendes A, Smok G, Burgos AM. Histological findings in the liver before and after gastric bypass. Obes Surg. 2006;16(5):607-611.
9. Mottin CC, Moretto M, Padoin AV, et al. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obes Surg. 2005;15(6):788-793.
10. Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004;39(6):1647-1654.
11. Wang RT, Koretz RL, Yee HF Jr. Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review. Am J Med. 2003;115(7):554-559.
12. Hoy MK, Heshka S, Allison DB, et al. Reduced risk of liver-function-test abnormalities and new gallstone formation with weight loss on 3350-kJ (800-kcal) formula diets. Am J Clin Nutr. 1994;60(2):249-254.
13. Anderson JW, Conley SB, Nicholas AS. One hundred pound weight losses with an intensive behavioral program: changes in risk factors in 118 patients with long-term follow-up. Am J Clin Nutr. 2007;86(2):301-307.
14. Furlow EA, Anderson JW. A systematic review of targeted outcomes associated with a medically supervised commercial weight-loss program. J Am Diet Assoc. 2009;109(8):1417-1421.
15. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-438.
16. Olsson R, Lindstedt G. Evaluation of tests for Gilbert's syndrome. Acta Med Scand. 1980;207(5):425-428.
17. Hirschfield GM, Alexander GJ. Gilbert's syndrome: an overview for clinical biochemists. Ann Clin Biochem. 2006;43(pt 5):340-343.
18. Gasteyger C, Larsen TM, Vercruysse F, Astrup A. Effect of a dietary-induced weight loss on liver enzymes in obese subjects. Am J Clin Nutr. 2008;87(5):1141-1147.